This is a competing renewal of an R01 grant to study regulation of gamma-herpesvirus reactivation from latency. Gamma-herpesviruses are associated with the development of lymphoproliferative disorders and lymphoma, particularly in immunosuppressed individuals. A detailed understanding of how virus replication is triggered is critical to understanding the biology of gamma-herpesvirus infections, and may identify possible targets for interfering with viral persistence in the host. In this renewal application we propose to characterize reactivation from latency focusing on both EBV and murine gamma-herpesvirus 68 (.HV68). .HV68 infection of mice provides a tractable small animal model system for characterizing the role of specific genes to viral pathogenesis and maintenance of chronic infection.
Aim 1. Regulation of EBV reactivation: 1a. Develop and characterize experimental systems for examining EBV reactivation. 1b. Determine the role of Zta and Rta autoactivation of Zp and Rp in virus reactivation. 1c. Determine the roles of individual cis-elements in regulating basal and induced levels of BRLF1and BZLF1 gene transcription. 1d. Determine the roles of specific cellular factors in regulating Zp and Rp activity.
Aim 2. Regulation of gammaHV68 reactivation: 2a. Identify signaling pathways that trigger gammaHV68 reactivation. 2b. Identify and characterize cis-elements regulating gene 50 (Rta) expression. 2c. Characterize the roles of the gammaHV68 M1 protein and v-cyclin in reactivation. 2d. Identify other gammaHV68 genes involved in reactivation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA052004-17
Application #
6931626
Study Section
Virology Study Section (VR)
Program Officer
Daschner, Phillip J
Project Start
1990-04-18
Project End
2008-05-31
Budget Start
2005-08-01
Budget End
2006-05-31
Support Year
17
Fiscal Year
2005
Total Cost
$338,400
Indirect Cost
Name
Emory University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Wakeman, Brian S; Johnson, L Steven; Paden, Clinton R et al. (2014) Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA. J Virol 88:5474-90
Reese, T A; Wakeman, B S; Choi, H S et al. (2014) Helminth infection reactivates latent ?-herpesvirus via cytokine competition at a viral promoter. Science 345:573-7
Stahl, James A; Paden, Clinton R; Chavan, Shweta S et al. (2012) Amplification of JNK signaling is necessary to complete the murine gammaherpesvirus 68 lytic replication cycle. J Virol 86:13253-62
Paden, Clinton R; Forrest, J Craig; Tibbetts, Scott A et al. (2012) Unbiased mutagenesis of MHV68 LANA reveals a DNA-binding domain required for LANA function in vitro and in vivo. PLoS Pathog 8:e1002906
Collins, Christopher M; Speck, Samuel H (2012) Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo. PLoS One 7:e33230
Gray, Kathleen S; Collins, Christopher M; Speck, Samuel H (2012) Characterization of omental immune aggregates during establishment of a latent gammaherpesvirus infection. PLoS One 7:e43196
Liang, Xiaozhen; Paden, Clinton R; Morales, Francine M et al. (2011) Murine gamma-herpesvirus immortalization of fetal liver-derived B cells requires both the viral cyclin D homolog and latency-associated nuclear antigen. PLoS Pathog 7:e1002220
Paden, Clinton R; Forrest, J Craig; Moorman, Nathaniel J et al. (2010) Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome. J Virol 84:7214-24
Gray, Kathleen S; Forrest, J Craig; Speck, Samuel H (2010) The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency. J Virol 84:4946-59
Siegel, Andrea M; Rangaswamy, Udaya Shankari; Napier, Ruth J et al. (2010) Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses. J Virol 84:674-85

Showing the most recent 10 out of 51 publications